Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Kidney International|March 3, 2019
Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantationTheresa M Wewers, Anna B Mayer, Alexander Pfleiderer, et al.Anesthesiology|May 26, 2005
Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitroTorsten Loop, David Dovi-Akue, Michael Frick, et al.Oncotarget|December 14, 2018
Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imagingAlborz Adeli, Katharina Hess, Christian Mawrin, et al.Molecular Pharmacology|September 20, 2007
Repression of T-cell function by thionamides is mediated by inhibition of the activator protein-1/nuclear factor of activated T-cells pathway and is associated with a common structureMatjaz Humar, Hannah Dohrmann, Philipp Stein, et al.Plos One|January 24, 2020
Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatmentHolger Ottensmeier, Paul G Schlegel, Matthias Eyrich, et al.Journal of Neurology|November 18, 2018
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessationSteffen Pfeuffer, Rene Schmidt, Frederike Anne Straeten, et al.Acta Neuropathologica|May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohortTorsten Pietsch, Rene Schmidt, Marc Remke, et al.BMJ Open|October 21, 2018
Improve hip fracture outcome in the elderly patient (iHOPE): a study protocol for a pragmatic, multicentre randomised controlled trial to test the efficacy of spinal versus general anaesthesiaAna Kowark, Christian Adam, Jörg Ahrens, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markersAndré Oberthuer, Dilafruz Juraeva, Barbara Hero, et al.Nature|October 16, 2015
Telomerase activation by genomic rearrangements in high-risk neuroblastomaMartin Peifer, Falk Hertwig, Frederik Roels, et al.Pageof 8